Threonine production by regulatory mutants of Serratia marcescens.
beta-Hydroxynorvaline (alpha-amino-beta-hydroxyvaleric acid)-resistant mutants of Serratia marcescens deficient in both threonine dehydrogenase and threonine deaminase were isolated and characterized. One of the mutants, strain HNr21, lacked feedback inhibition of threonine-sensitive aspartokinase and homoserine dehydrogenase, was repressed for the two enzymes, and produced 11 mg of threonine per ml of medium containing a limiting amount of isoleucine. The other mutant, strain HNr59, was constitutively derepressed for aspartokinase and homoserine dehydrogenase. Its kinase was sensitive to feedback inhibition, but its dehydrogenase was insensitive to feedback inhibition. This strain produced 5 mg of threonine per ml of medium containing either a limiting or an excess amount of isoleucine. Diaminopimelate auxotrophs derived from strain HNr59 produced more threonine (13 mg/ml) than the parent strain. However, similar auxotrophs derived from strain HNr21 produced the same amount of threonine as that produced by the parent strain.
D001222:Aspartate Kinase / Q000378:metabolism; D003960:Diaminopimelic Acid / Q000378:metabolism; D004352:Drug Resistance, Microbial; D006715:Homoserine Dehydrogenase / Q000378:metabolism; D007532:Isoleucine / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D009154:Mutation; D012706:Serratia marcescens / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D013912:Threonine / Q000031:analogs & derivatives / Q000096:biosynthesis* / Q000494:pharmacology
D007532:Isoleucine; C010994:3-hydroxynorvaline; D013912:Threonine; D003960:Diaminopimelic Acid; D006715:Homoserine Dehydrogenase; D001222:Aspartate Kinase; D008239:Lysine